![]() |
||
2012 Presenting Companies |
||
ABPathfinder helps kids with Autism gain skills faster by making their therapists more efficient and effective. Therapists use ABPathfinder as a comprehensive technology solution for streamlining intervention planning and data management to improve individualized patient outcomes, increasing control and consistency over therapy delivery, reducing staff training time and allowing therapists to focus on their practice. In the end, more kids will get the help they need to participate in society. |
||
Altheus Therapeutics is developing Zoenasa® as an innovative treatment for ulcerative colitis to meet the strong medical need for new therapies in this area. To build on a successful Phase 1 trial, Altheus is raising funds to complete a double-blind, randomized Phase 2 study of Zoenasa Rectal Gel, ZA201, along with other development activities that will position the company for a strategic partnership and potential liquidity event. The Company's original investor syndicate, joined by a new investor, has completed a first closing for this round, which has been supplemented by an economic development grant from the State of Oklahoma. Altheus recently randomized its first patient in ZA201, and plans to enroll approximately 120 patients at 25+ centers across the United States. The company is continuing development of an oral formulation of Zoenasa for proximal ulcerative colitis in adults. |
||
DigiPath, Inc. provides the next generation of affordable, innovative, and reliable digital pathology solutions. DigiPath's advisors bring over 60 years combined expertise in pioneering digital pathology, implementing over 750 installations at community pathology practices, hospitals, academic medical centers, reference laboratories, biopharma organizations, and life science research institutions worldwide. |
||
![]() |
Elevated Health Systems, LLC (EHS) develops, manufactures and distributes its patented automated UVC germicidal light technology to healthcare and other industries. As a result of the current healthcare environment, with its crisis levels of infections and the expanding Federal laws that will publicize the rates of Hospital Acquired Infections, the market demand is extremely strong for safe and effective solutions. The ESP-DLux™ germicidal light is completing prototype testing at a hospital in Wichita, KS and will be ready for full production in November, 2012. |
|
Flow Forward Medical, LLC ("Flow Forward") is developing the Arteriovenous Fistula Eligibility (AFE) System™, a cardiovascular medical device for improving eligibility and reducing maturation failure of arteriovenous fistula (AVF) vascular access sites for hemodialysis. The AFE System is a small, wearable, temporary, minimally-invasive rotary blood pump system designed to rapidly and persistently dilate veins prior to AVF surgery. The AFE System will enable AVF placement in nearly all hemodialysis patients and reduce AVF maturation failure rates, leading to lower morbidity and mortality rates, and a reduction in the cost of care. Flow Forward was formed in August 2010 as a subsidiary of Novita Therapeutics, LLC ("Novita"), with headquarters at the Kansas Bioscience Authority Venture Accelerator in Olathe, KS. |
||
Green Dot is a new bioscience social enterprise based in Cottonwood Falls, Kansas. The company was recently named as one of the top 25 American social entrepreneurs by Bloomberg Businessweek. Green Dot is introducing the market's first compostable elastomeric bioplastic, GDH-B1. Unlike other bioplastics, GDH-B1 is a soft rubber-like material that's strong, pliable and durable. It's not just greener, it's better. Green Dot is placing this pioneering compostable bioplastic in the hands of millions of consumers with innovative products for stylish consumers |
||
Iron Mountain Products, LLC has developed the Steinman Deer Recovery System™. This system is a revolutionary new product designed to aid the bow hunter in locating mortally wounded game when traditional tracking techniques fail. It consists of a miniature, microelectronics transmitter and a state-of-the-art, digital receiver that picks up the signal up to a mile away. The company intends to become a category leader and further develop products around its core technology and distribution channels. |
||
Leap2, LLC is a mobile search company based in Kansas City, KS. Leap2 is the first mobile search application that combines search with instant web and real-time social results. Leap2 is built on a Living SearchT platform that provides real-time information and searches to "live on" to alert users when new relevant information is published. Leap2 has been featured by Sprint (as the "App of the Week"), Silicon Prairie News "App of the Year" Finalist, Startup America, Microsoft (Pavillion at SXSW 2012), the Kauffman Foundation's Demo Day, Silicon Prairie News Top 10 Startups to Watch in 2012 and was also selected as one of 10 startups in the United States invited to the White House for the signing of the JOBS Act. Leap2 is currently available on iOS, and Android. |
||
Metactive Medical™, LLC ("Metactive") is developing novel, catheter-based cardiovascular medical devices. Metactive's first product, the Ballstent Microcatheter™, is designed to rapidly and completely fill and seal cerebral aneurysms with one simple device deployment, offering an easier, faster, and more durable repair at a reduced overall cost. Metactive is also developing the Blockstent MicrocatheterT to provide a similarly rapid and complete solution for occlusion of peripheral arteries and veins. Metactive was formed in August 2011 as a subsidiary of Novita Therapeutics, LLC ("Novita"), with headquarters at the Kansas Bioscience Authority Venture Accelerator in Olathe, KS. |
||
RareWire was founded in March 2010 with the mission to provide a software platform that makes it easy to create and manage mobile apps for native devices. Today, we are witnessing the explosion of the smart mobile device era. In 2011 companies spent $20.5 billion on mobile app development; that number is expected to approach $100 billion in 2015. The challenge is finding an easy, cost effective way to create and manage mobile apps. Traditionally, mobile app developers have been an expensive, highly trained and specialized group of programmers. RareWire is here to change that paradigm! |
||
Revdel has created a product that has been revolutionizing the way organizations communicate since 2010. RED is the most comprehensive communication solution on the market today for education (K12, higher ed.), religious organizations, nonprofits, businesses, government, chambers of commerce, and more; enabling them to more quickly and effectively engage their members. By leveraging the power of text, email, and social media messaging, and combining it with feature-rich, cloud-based event scheduling, RED saves staff time and money, while boosting their reach and influence. |
||
Founded in 2011, Ulterius Technologies is an Access Customer Premises Equipment (CPE) solution provider headquartered in Wichita, KS. As such Ulterius Tech provides highly scalable converged communications and entertainment services to enterprise and residential customers. Ulterius Tech's founding members and executive team consists of seasoned telecommunications professionals who dedicated their careers to converged communications services AND received industry wide recognition through their innovations. |
||
Waffle-Crete International, Inc. (WCI) is the developer of a patented precast concrete building system that enables rapid and affordable construction of durable, low maintenance structures. The Waffle-Crete Building System also dramatically simplifies the overall construction process such that unskilled workers can erect precision built structures in a fraction of the time of conventional construction methods. Waffle-Crete has customers in more than 30 countries that have successfully employed the Waffle-Crete System on thousands of projects. The company is now taking their innovative product to the $330B affordable housing market. |
||
Copyright©
Great Plains Capital Conference. All rights reserved. | General
Conditions & Legal Notices | Privacy
Statement | Contact Us
|
||